Stealth BioTherapeutics (Stealth BioTherapeutics) Change In Receivables : $0.00 Mil (TTM As of Mar. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics Change In Receivables?

Stealth BioTherapeutics's change in receivables for the quarter that ended in Mar. 2022 was $0.00 Mil. It means Stealth BioTherapeutics's Accounts Receivable stayed the same from Dec. 2021 to Mar. 2022 .

Stealth BioTherapeutics's change in receivables for the fiscal year that ended in Dec. 2021 was $0.00 Mil. It means Stealth BioTherapeutics's Accounts Receivable stayed the same from Dec. 2020 to Dec. 2021 .

Stealth BioTherapeutics's Accounts Receivable for the quarter that ended in Mar. 2022 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Stealth BioTherapeutics's liquidation value for the three months ended in Mar. 2022 was $-55.40 Mil.

Stealth BioTherapeutics Change In Receivables Historical Data

The historical data trend for Stealth BioTherapeutics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stealth BioTherapeutics Change In Receivables Chart

Stealth BioTherapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Change In Receivables

Get a 7-Day Free Trial

Stealth BioTherapeutics Quarterly Data
	Dec16	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Stealth BioTherapeutics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Stealth BioTherapeutics (NAS:MITO) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Stealth BioTherapeutics's Days Sales Outstanding for the quarter that ended in Mar. 2022 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Stealth BioTherapeutics's accounts receivable are only considered to be worth 75% of book value:

Stealth BioTherapeutics's liquidation value for the quarter that ended in Mar. 2022 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	33.834	-	89.232	+	0.75 * 0	+	0.5 * 0
=	-55.40

Stealth BioTherapeutics Change In Receivables Related Terms

Thank you for viewing the detailed overview of Stealth BioTherapeutics's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005

Website

https://www.stealthbt.com

Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.